CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Millions, unless otherwise specified	9 Months Ended
Sep. 30, 2014	Sep. 30, 2013
Cash flow from operating activities:
Net income	$ 529.4	$ 420.4
Adjustments to reconcile Net income to net Cash flow from operating activities:
Intangible amortization and impairments	84.2	98.1
Depreciation and other amortization	12.3	10.3
Deferred income tax provision	49.6	24.0
Imputed interest expense and contingent payment arrangements	27.6	26.5
Income from equity method investments, net of amortization	(152.6)	(121.0)
Distributions received from equity method investments	315.4	187.2
Share-based compensation and Affiliate equity expense	82.2	37.6
Other non-cash items	4.8	15.4
Changes in assets and liabilities:
Increase in receivables	(95.1)	(125.4)
Increase in other assets	(6.8)	(13.9)
Increase in payables, accrued liabilities and other liabilities	179.4	188.4
Cash flow from operating activities	1,030.4	747.6
Cash flow from (used in) investing activities:
Investments in Affiliates	(534.4)	(26.3)
Purchase of fixed assets	(13.7)	(15.9)
Purchase of investment securities	(16.8)	(6.3)
Sale of investment securities	13.9	4.7
Cash flow used in investing activities	(551.0)	(43.8)
Cash flow from (used in) financing activities:
Borrowings of senior debt	1,016.5	595.0
Repayments of senior debt and convertible securities	(895.6)	(986.3)
Issuance of common stock	37.9	47.7
Repurchase of common stock	(51.7)	(15.7)
Note and contingent payments	12.1	(36.7)
Distributions to non-controlling interests	(468.3)	(218.6)
Affiliate equity issuances and repurchases	(44.8)	(6.7)
Excess tax benefit from exercise of stock options	58.6	17.1
Settlement of forward equity sale agreement	(45.0)	0
Other financing items	(5.2)	(7.4)
Cash flow used in financing activities	(385.5)	(611.6)
Effect of foreign exchange rate changes on cash and cash equivalents	(3.3)	(0.2)
Net decrease in cash and cash equivalents	90.6	92.0
Cash and cash equivalents at beginning of period	469.6	430.4
Cash and cash equivalents at end of period	560.2	522.4
Supplemental disclosure of non-cash financing activities:
Settlement of 2006 junior convertible securities	217.8	0
Stock issued under other incentive plans	(63.6)	(1.1)
Stock received in settlement of liability	44.7	0.4
Payables recorded for Affiliate equity repurchases	20.5	30.5
Payables recorded for forward equity sale settlements	$ 0	$ 22.5

The aggregate expense charged against earnings to allocate the cost of tangible assets to periods in which the assets are used and held and to allocate the cost of issuing debt to periods in which the debt is outstanding. As a noncash expense, this element is added back to net income when calculating cash provided by (used in) operations using the indirect method.

No definition available.